By Chelsea Naso ( December 9, 2014, 4:28 PM EST) -- Juno Therapeutics Inc. fine-tuned its initial public offering Tuesday, setting terms for a $153 million float that would make it the largest biotech of 2014 by diluted market capitalization, as fellow cancer immunotherapy developer Bellicum Pharmaceuticals Inc. inched closer to its own $100 million offering....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.